病毒性肝炎治疗之困惑如何评价抗炎保肝价值？ ppt课件资料讲解.pptxVIP

;Natural History of Chronic Hepatitis B;Cumulative Incidence of Cirrhosis by Serum HBV DNA Level at Study Entry;REVEAL: Relationship Between Baseline HBV DNA and Cirrhosis;Cumulative Incidence of HCC by Serum HBV DNA Level at Study Entry;Successful Hepatitis B Treatment Reduces Clinical Endpoints; 90%Hepatocellular carcinoma (HCC) patients had serious inflammation and fibrosis;抗病毒治疗是否能解决所有问题？;HBeAg阳性慢乙肝患者治疗一年ALT的复常率;HBsAg/HBeAg血清状态和ALT校正HCC的风险比;ALT居高不下是CHB严重不良预后的重要危险因素之一;CHB病人经抗病毒治疗后ALT复常率常不理想;15;抗病毒治疗后病毒耐药导致肝脏炎症加重;80;延长NUCs抗病毒时间，肝纤维化改善率仍不理想;不规范停药导致肝炎复发;抗病毒治疗并不能解决所有问题;No inflammation，no live